Teaching hospital Program year 2025 Source: CMS Open Payments

Univ of MI Hospitals & Hlth Ctrs

CCN 230046 CMS hospital 16261

Open in the dashboard

General payments

$153,367,462

3,527 payments

Research payments

$281,652,295

23,311 payments

Through program year 2025, Univ of MI Hospitals & Hlth Ctrs is reported as receiving $153,367,462 in general payments and $281,652,295 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows

General

’19 ’20 ’21 ’22 ’23 ’24 ’25

Peak $31.6M

Research

’19 ’20 ’21 ’22 ’23 ’24 ’25

Peak $45.9M

Year	Kind	Amount	Payments
2025	General	$31,635,791	378
2025	Research	$41,712,805	3,907
2024	General	$26,669,624	435
2024	Research	$41,166,689	3,978
2023	General	$23,127,400	532
2023	Research	$42,310,638	3,249
2022	General	$18,950,009	553
2022	Research	$45,947,731	2,778
2021	General	$21,277,928	334
2021	Research	$42,158,748	3,085
2020	General	$20,050,261	627
2020	Research	$37,417,544	2,991
2019	General	$11,656,450	668
2019	Research	$30,938,139	3,323

Breakdown

Who paid General payments · program years 2019–2025

Genzyme Corporation $95,275,882 72 payments
AstraZeneca Pharmaceuticals LP $11,537,590 77 payments
Takeda Pharmaceuticals U.S.A., Inc. $11,215,076 60 payments
AstraZeneca AB $4,779,748 13 payments
Boston Scientific Corporation $2,005,982 36 payments
Novo Nordisk AS $1,825,103 9 payments
Histosonics, Inc. $1,773,719 1 payment
Genentech, Inc. $1,761,520 39 payments
Pfizer Inc. $1,418,555 59 payments
Janssen Research & Development, LLC $1,055,698 26 payments
Other $20,718,590 3,135 payments

What the payments were for General payments · program years 2019–2025

Royalty or License $124,948,498 579 payments
Grant $10,131,959 369 payments
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,617,060 952 payments
Space rental or facility fees (teaching hospital only) $3,413,247 682 payments
Consulting Fee $2,730,918 124 payments
Gift $909,211 72 payments
Education $831,939 524 payments
Charitable Contribution $796,300 88 payments
Long term medical supply or device loan $582,237 60 payments
Current or prospective ownership or investment interest $290,274 2 payments
Other $115,820 75 payments

Products named General payments · program years 2019–2025

Cerdelga Genetic Disease $54,364,935 19 payments
Cerdelga Rare Disease Genetics $7,551,618 5 payments
Flumist Quadrivalent Respiratory $2,632,547 4 payments
Flumist Quadrivalent Respiratory $2,269,400 3 payments
Flumist $2,217,779 1 payment
Flumist Quadrivalent Respiratory $978,488 3 payments
Gastroscopes $642,135 8 payments
BF Videoscopes $522,729 5 payments
Colonoscopes $505,786 5 payments
NanoKnife $475,500 9 payments
Other $12,910,269 2,370 payments

A payment can name more than one product, so these amounts overlap.

Records

3,527 general · 23,311 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.